Fluorine in PDB 8d0h: Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Enzymatic activity of Human SARM1 Tir Domain Bound to Nb-3-Gdpr
All present enzymatic activity of Human SARM1 Tir Domain Bound to Nb-3-Gdpr:
3.2.2.6;
Protein crystallography data
The structure of Human SARM1 Tir Domain Bound to Nb-3-Gdpr, PDB code: 8d0h
was solved by
M.A.Bratkowski,
P.Mathur,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.54 /
2.37
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
33.048,
77.707,
116.227,
90,
90,
90
|
R / Rfree (%)
|
19.3 /
28.1
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
(pdb code 8d0h). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human SARM1 Tir Domain Bound to Nb-3-Gdpr, PDB code: 8d0h:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 8d0h
Go back to
Fluorine Binding Sites List in 8d0h
Fluorine binding site 1 out
of 6 in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human SARM1 Tir Domain Bound to Nb-3-Gdpr within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:41.5
occ:1.00
|
F49
|
A:Q1O801
|
0.0
|
41.5
|
1.0
|
C48
|
A:Q1O801
|
1.4
|
31.6
|
1.0
|
F50
|
A:Q1O801
|
2.2
|
32.7
|
1.0
|
F51
|
A:Q1O801
|
2.2
|
39.0
|
1.0
|
C47
|
A:Q1O801
|
2.4
|
35.0
|
1.0
|
N46
|
A:Q1O801
|
2.9
|
36.6
|
1.0
|
O52
|
A:Q1O801
|
3.0
|
44.0
|
1.0
|
C45
|
A:Q1O801
|
3.2
|
41.6
|
1.0
|
CB
|
A:ASP594
|
3.4
|
24.9
|
1.0
|
CG
|
A:ASP594
|
3.6
|
31.1
|
1.0
|
C
|
A:ASP594
|
3.7
|
36.0
|
1.0
|
OD2
|
A:ASP594
|
3.7
|
34.3
|
1.0
|
N
|
A:VAL595
|
3.8
|
36.0
|
1.0
|
NH2
|
A:ARG570
|
3.8
|
44.8
|
1.0
|
O
|
A:ASP594
|
3.9
|
28.6
|
1.0
|
CA
|
A:VAL595
|
4.0
|
31.2
|
1.0
|
CD2
|
A:LEU598
|
4.1
|
30.6
|
1.0
|
C41
|
A:Q1O801
|
4.1
|
39.7
|
1.0
|
CG1
|
A:VAL595
|
4.1
|
31.1
|
1.0
|
CA
|
A:ASP594
|
4.1
|
26.9
|
1.0
|
N44
|
A:Q1O801
|
4.4
|
38.3
|
1.0
|
OD1
|
A:ASP594
|
4.4
|
29.0
|
1.0
|
CB
|
A:LEU598
|
4.4
|
20.9
|
1.0
|
C40
|
A:Q1O801
|
4.5
|
38.9
|
1.0
|
CZ
|
A:ARG570
|
4.7
|
41.0
|
1.0
|
CB
|
A:VAL595
|
4.8
|
26.6
|
1.0
|
CG
|
A:LEU598
|
4.8
|
25.7
|
1.0
|
C42
|
A:Q1O801
|
5.0
|
35.6
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 8d0h
Go back to
Fluorine Binding Sites List in 8d0h
Fluorine binding site 2 out
of 6 in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human SARM1 Tir Domain Bound to Nb-3-Gdpr within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:32.7
occ:1.00
|
F50
|
A:Q1O801
|
0.0
|
32.7
|
1.0
|
C48
|
A:Q1O801
|
1.4
|
31.6
|
1.0
|
F49
|
A:Q1O801
|
2.2
|
41.5
|
1.0
|
F51
|
A:Q1O801
|
2.2
|
39.0
|
1.0
|
C47
|
A:Q1O801
|
2.4
|
35.0
|
1.0
|
CA
|
A:VAL595
|
3.1
|
31.2
|
1.0
|
CG1
|
A:VAL595
|
3.5
|
31.1
|
1.0
|
N46
|
A:Q1O801
|
3.7
|
36.6
|
1.0
|
N
|
A:VAL595
|
3.7
|
36.0
|
1.0
|
O
|
A:ASP594
|
3.7
|
28.6
|
1.0
|
CB
|
A:VAL595
|
3.8
|
26.6
|
1.0
|
C
|
A:ASP594
|
3.9
|
36.0
|
1.0
|
C
|
A:VAL595
|
4.0
|
38.0
|
1.0
|
O
|
A:VAL595
|
4.2
|
46.0
|
1.0
|
O52
|
A:Q1O801
|
4.5
|
44.0
|
1.0
|
C45
|
A:Q1O801
|
4.6
|
41.6
|
1.0
|
N25
|
A:Q1O801
|
4.7
|
35.3
|
1.0
|
O
|
A:LEU598
|
4.8
|
33.7
|
1.0
|
CG
|
B:GLU686
|
4.9
|
25.9
|
1.0
|
CB
|
A:ASP594
|
4.9
|
24.9
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 8d0h
Go back to
Fluorine Binding Sites List in 8d0h
Fluorine binding site 3 out
of 6 in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human SARM1 Tir Domain Bound to Nb-3-Gdpr within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:39.0
occ:1.00
|
F51
|
A:Q1O801
|
0.0
|
39.0
|
1.0
|
C48
|
A:Q1O801
|
1.4
|
31.6
|
1.0
|
F49
|
A:Q1O801
|
2.2
|
41.5
|
1.0
|
F50
|
A:Q1O801
|
2.2
|
32.7
|
1.0
|
C47
|
A:Q1O801
|
2.4
|
35.0
|
1.0
|
N46
|
A:Q1O801
|
2.9
|
36.6
|
1.0
|
O
|
A:LEU598
|
3.4
|
33.7
|
1.0
|
CD2
|
A:LEU598
|
3.4
|
30.6
|
1.0
|
CB
|
A:LEU598
|
3.4
|
20.9
|
1.0
|
O
|
A:ASP594
|
3.6
|
28.6
|
1.0
|
CG
|
A:LEU598
|
3.7
|
25.7
|
1.0
|
C45
|
A:Q1O801
|
4.0
|
41.6
|
1.0
|
C
|
A:ASP594
|
4.2
|
36.0
|
1.0
|
C
|
A:LEU598
|
4.2
|
36.1
|
1.0
|
CA
|
A:LEU598
|
4.4
|
26.3
|
1.0
|
O52
|
A:Q1O801
|
4.4
|
44.0
|
1.0
|
CA
|
A:VAL595
|
4.6
|
31.2
|
1.0
|
N
|
A:VAL595
|
4.6
|
36.0
|
1.0
|
CB
|
A:ASP594
|
4.7
|
24.9
|
1.0
|
CA
|
A:ASP594
|
4.9
|
26.9
|
1.0
|
N
|
A:LEU598
|
4.9
|
32.6
|
1.0
|
N44
|
A:Q1O801
|
5.0
|
38.3
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 8d0h
Go back to
Fluorine Binding Sites List in 8d0h
Fluorine binding site 4 out
of 6 in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human SARM1 Tir Domain Bound to Nb-3-Gdpr within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:33.3
occ:1.00
|
F49
|
B:Q1O801
|
0.0
|
33.3
|
1.0
|
C48
|
B:Q1O801
|
1.4
|
33.7
|
1.0
|
F50
|
B:Q1O801
|
2.2
|
42.1
|
1.0
|
F51
|
B:Q1O801
|
2.2
|
31.3
|
1.0
|
C47
|
B:Q1O801
|
2.4
|
35.5
|
1.0
|
N46
|
B:Q1O801
|
2.7
|
43.9
|
1.0
|
NH2
|
B:ARG570
|
2.9
|
43.7
|
1.0
|
O52
|
B:Q1O801
|
2.9
|
41.6
|
1.0
|
C45
|
B:Q1O801
|
3.0
|
42.9
|
1.0
|
OD2
|
B:ASP594
|
3.3
|
29.5
|
1.0
|
CB
|
B:ASP594
|
3.5
|
28.2
|
1.0
|
CG
|
B:ASP594
|
3.5
|
29.8
|
1.0
|
C
|
B:ASP594
|
3.8
|
27.9
|
1.0
|
O
|
B:ASP594
|
3.8
|
27.5
|
1.0
|
C41
|
B:Q1O801
|
3.9
|
32.2
|
1.0
|
N
|
B:VAL595
|
4.1
|
28.7
|
1.0
|
N44
|
B:Q1O801
|
4.2
|
37.9
|
1.0
|
CZ
|
B:ARG570
|
4.2
|
46.1
|
1.0
|
CD2
|
B:LEU598
|
4.2
|
31.9
|
1.0
|
CA
|
B:ASP594
|
4.2
|
30.0
|
1.0
|
OD1
|
B:ASP594
|
4.3
|
30.7
|
1.0
|
CA
|
B:VAL595
|
4.3
|
31.3
|
1.0
|
CB
|
B:LEU598
|
4.5
|
26.0
|
1.0
|
C40
|
B:Q1O801
|
4.5
|
33.4
|
1.0
|
CG1
|
B:VAL595
|
4.6
|
35.1
|
1.0
|
NE
|
B:ARG570
|
4.8
|
46.3
|
1.0
|
C42
|
B:Q1O801
|
4.8
|
31.4
|
1.0
|
CG
|
B:LEU598
|
4.9
|
37.8
|
1.0
|
C53
|
B:Q1O801
|
4.9
|
33.6
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 8d0h
Go back to
Fluorine Binding Sites List in 8d0h
Fluorine binding site 5 out
of 6 in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human SARM1 Tir Domain Bound to Nb-3-Gdpr within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:42.1
occ:1.00
|
F50
|
B:Q1O801
|
0.0
|
42.1
|
1.0
|
C48
|
B:Q1O801
|
1.4
|
33.7
|
1.0
|
F49
|
B:Q1O801
|
2.2
|
33.3
|
1.0
|
F51
|
B:Q1O801
|
2.2
|
31.3
|
1.0
|
C47
|
B:Q1O801
|
2.4
|
35.5
|
1.0
|
CA
|
B:VAL595
|
3.3
|
31.3
|
1.0
|
CG1
|
B:VAL595
|
3.6
|
35.1
|
1.0
|
N46
|
B:Q1O801
|
3.7
|
43.9
|
1.0
|
O
|
B:ASP594
|
3.8
|
27.5
|
1.0
|
N
|
B:VAL595
|
3.8
|
28.7
|
1.0
|
NH2
|
B:ARG570
|
3.9
|
43.7
|
1.0
|
C
|
B:ASP594
|
4.0
|
27.9
|
1.0
|
CB
|
B:VAL595
|
4.0
|
35.0
|
1.0
|
OE1
|
A:GLU686
|
4.1
|
58.7
|
1.0
|
O
|
B:VAL595
|
4.1
|
41.5
|
1.0
|
C
|
B:VAL595
|
4.2
|
35.4
|
1.0
|
O52
|
B:Q1O801
|
4.3
|
41.6
|
1.0
|
O
|
A:HOH904
|
4.3
|
34.0
|
1.0
|
CD
|
A:GLU686
|
4.4
|
55.0
|
1.0
|
C45
|
B:Q1O801
|
4.4
|
42.9
|
1.0
|
OE2
|
A:GLU686
|
4.5
|
63.2
|
1.0
|
CG
|
B:ASP594
|
4.8
|
29.8
|
1.0
|
OD2
|
B:ASP594
|
4.8
|
29.5
|
1.0
|
CB
|
B:ASP594
|
4.9
|
28.2
|
1.0
|
CZ
|
B:ARG570
|
5.0
|
46.1
|
1.0
|
N25
|
B:Q1O801
|
5.0
|
46.1
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 8d0h
Go back to
Fluorine Binding Sites List in 8d0h
Fluorine binding site 6 out
of 6 in the Human SARM1 Tir Domain Bound to Nb-3-Gdpr
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human SARM1 Tir Domain Bound to Nb-3-Gdpr within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:31.3
occ:1.00
|
F51
|
B:Q1O801
|
0.0
|
31.3
|
1.0
|
C48
|
B:Q1O801
|
1.4
|
33.7
|
1.0
|
F49
|
B:Q1O801
|
2.2
|
33.3
|
1.0
|
F50
|
B:Q1O801
|
2.2
|
42.1
|
1.0
|
C47
|
B:Q1O801
|
2.4
|
35.5
|
1.0
|
N46
|
B:Q1O801
|
3.0
|
43.9
|
1.0
|
O
|
B:ASP594
|
3.3
|
27.5
|
1.0
|
CB
|
B:LEU598
|
3.5
|
26.0
|
1.0
|
O
|
B:LEU598
|
3.9
|
39.0
|
1.0
|
CD2
|
B:LEU598
|
3.9
|
31.9
|
1.0
|
C
|
B:ASP594
|
4.0
|
27.9
|
1.0
|
CG
|
B:LEU598
|
4.0
|
37.8
|
1.0
|
C45
|
B:Q1O801
|
4.1
|
42.9
|
1.0
|
CA
|
B:VAL595
|
4.4
|
31.3
|
1.0
|
C
|
B:LEU598
|
4.4
|
37.0
|
1.0
|
CA
|
B:LEU598
|
4.4
|
28.1
|
1.0
|
O52
|
B:Q1O801
|
4.5
|
41.6
|
1.0
|
N
|
B:VAL595
|
4.5
|
28.7
|
1.0
|
CB
|
B:ASP594
|
4.6
|
28.2
|
1.0
|
CA
|
B:ASP594
|
4.8
|
30.0
|
1.0
|
O
|
B:VAL595
|
4.8
|
41.5
|
1.0
|
N
|
B:LEU598
|
4.9
|
33.3
|
1.0
|
C
|
B:VAL595
|
4.9
|
35.4
|
1.0
|
|
Reference:
M.Bratkowski,
T.C.Burdett,
J.Danao,
X.Wang,
P.Mathur,
W.Gu,
J.A.Beckstead,
S.Talreja,
Y.S.Yang,
G.Danko,
J.H.Park,
M.Walton,
S.P.Brown,
C.M.Tegley,
P.R.B.Joseph,
C.H.Reynolds,
S.Sambashivan.
Uncompetitive, Adduct-Forming SARM1 Inhibitors Are Neuroprotective in Preclinical Models of Nerve Injury and Disease. Neuron V. 110 3711 2022.
ISSN: ISSN 0896-6273
PubMed: 36087583
DOI: 10.1016/J.NEURON.2022.08.017
Page generated: Fri Aug 2 17:19:15 2024
|